Bros, M; Boissel, JP; Godtel-Armbrust, U et al.
The untranslated region of exon 2 of the human neuronal nitric oxide synthase (NOS1) gene exerts regulatory activity.Gene. Bd. 405. H. 1-2. 2007 S. 36-46
Steinkamp-Fenske, K; Bollinger, L; Völler, N et al.
Ursolic acid from the Chinese herb danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells.Atherosclerosis. Bd. 195. H. 1. 2007 S. e104-11
Gödtel-Armbrust, U; Metzger, A; Kroll, U et al.
Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.Naunyn Schmiedebergs Arch Pharmacol. Bd. 375. H. 6. 2007 S. 377-82
Rotmann, A; Vekony, N; Gassner, D et al.
Activation of classical protein kinase C reduces the expression of human cationic amino acid transporter 3 (hCAT-3) in the plasma membrane.Biochem J. Bd. 395. H. 1. 2006 S. 117-23
Wojnowski, L
ADHD drugs and cardiovascular riskN Engl J Med. Bd. 354. H. 21. 2006 S. 2296-8; author reply 2296-8
Niemi, M; Arnold, KA; Backman, JT et al.
Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.Pharmacogenet Genomics. Bd. 16. H. 11. 2006 S. 801-8
Wojnowski, L; Kamdem, LK
Clinical implications of CYP3A polymorphisms.Expert Opin Drug Metab Toxicol. Bd. 2. H. 2. 2006 S. 171-82
Pommerening, K; Muscholl, M
Datenschutz und DatensicherheitB. Herbig, A. Büssing (Hrsg). Informations- und Kommunikationstechnologien im Krankenhaus. Stuttgart: Schattauer Verlag 2006
Kamdem, LK; Meineke, I; Gödtel-Armbrust, U et al.
Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1.Chem Res Toxicol. Bd. 19. H. 4. 2006 S. 577-86
Förstermann, U; Münzel, T
Endothelial nitric oxide synthase in vascular disease: from marvel to menace.Circulation. Bd. 113. H. 13. 2006 S. 1708-14